This is a VIRTUAL event.

Join us on Saturday, December 9th at Noon Pacific to learn more about minimally invasive liver directed therapies targeting liver metastases with interventional radiologist Dr. Koethe. She discusses ablations including the recently approved histotripsy and embolizations including bland, chemo and radioembolization. There will be a live Q&A following the presentation. 

Submit your questions below.

ABOUT DR. YILUN KOETHE

Dr. Koethe is an interventional radiologist at TRG Imaging in Portland, OR. She is also proud to have been the former Director of Interventional Oncology and Assistant Professor at Oregon Health & Science University (OHSU). She is an expert in interventional oncology with a focus on primary and metastatic liver cancer including neuroendocrine disease, and created the first irreversible electroporation and liver venous deprivation program in Oregon. Furthermore, she has gained international recognition for her expertise in genicular artery embolization for knee arthritis.

Previously, Dr. Koethe graduated summa cum laude from Tufts University. She obtained her medical degree from Duke University. Following medical school, she completed an internship at Santa Clara Valley Medical Center. She did her residency in Diagnostic Radiology at the University of California, San Francisco. Following residency, she further subspecialized in Vascular and Interventional Radiology at the Miami Cardiac & Vascular Institute.

Dr. Koethe is committed to providing individualized, evidence-based care for each of her patients. She has long served on numerous national and international society committees and scientific journals and has had over 60 scientific presentations and publications. She is currently the Vice Chair of the Early Career Section of the Society of Interventional Oncology and serves on committees with the Society of Interventional Oncology and the American Board of Radiology as well.